10x Genomics Inc. (TXG)
Summary
TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences
10x Genomics wins a $4.8M patent verdict against Parse, strengthening its IP position as it seeks added damages and a U.S. injunction.
10x Genomics: The Turnaround Is Real, But Atera Now Has To Deliver (Rating Upgrade)
Atera could meaningfully boost instrument sales in late 2026 and drive recurring high-margin consumables revenue from 2027 onward. TXG's valuation already prices in significant Atera success, but the risk/reward remains skewed to the upside with favorable chart dynamics. Key risks include Atera manufacturing constraints, potential cannibalization of Xenium, rising competition, and ongoing share dilution.
10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up
TXG beats Q2 earnings and revenue estimates, expands gross margin and raises its 2026 revenue outlook despite a year-over-year sales decline.
10x Genomics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 371 | $5,138.01 | $17,607.66 | $12,469.65 | 242.69% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 9,308 | $356,870 | $484,295.23 | $127,425.23 | 35.71% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 287 | $4,839.51 | $16,783.76 | $11,944.25 | 246.81% |
| NA Nizar Araji National Bank Of Canada /FI/ | 418 | $6,114.24 | $21,788.25 | $15,674.01 | 256.35% |
| BG Bart Gancher Intech Investment Management LLC | 26,839 | $334,296.81 | $1.4M | $1.06M | 318.49% |
10x Genomics Inc. (TXG) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has 10x Genomics Inc. ever had a stock split?
10x Genomics Inc. Profile
| Life Sciences Tools & Services Industry | Healthcare Sector | Serge Saxonov CEO | NASDAQ (NGS) Exchange | 88025U109 CUSIP |
| US Country | 1,178 Employees | - Last Dividend | 17 Jul 2006 Last Split | 12 Sep 2019 IPO Date |
Overview
10x Genomics, Inc. is a prominent life science technology company known for its innovative development and commercialization of instruments, consumables, and software aimed at analyzing biological systems. The company's footprint extends across the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific regions, catering to a diverse clientele that includes academic, government, biopharmaceutical, biotechnology, and other institutions. Originally named 10X Technologies, Inc., it underwent a rebranding to 10x Genomics, Inc. in November 2014. Since its inception in 2012, 10x Genomics has established its headquarters in Pleasanton, California, positioning itself as a leader in the field of genomics and cellular analysis.
Products and Services
- Chromium Instruments: This product line includes the chromium, chromium connect, and chromium controller instruments. These are cornerstone tools for 10x Genomics, facilitating a range of single cell solutions that enable researchers to delve into the intricacies of gene activity and networks on a cell-by-cell basis. The chromium instruments are complemented by microfluidic chips, slides, reagents, and other essential consumables.
- Single Cell Solutions:
- Single Cell Gene Expression: This solution measures gene activity and networks at the individual cell level, providing detailed insights into cellular functions.
- Single Cell Immune Profiling: Targeted at studying the immune system, this solution offers a detailed look at immune cell interactions and functions.
- Single Cell Assay for Transposase Accessible Chromatin (ATAC): Designed to explore the epigenetic landscape of cells, this solution unveils how the accessibility of chromatin influences gene expression.
- Single Cell Multiome ATAC + Gene Expression: This solution allows for the simultaneous investigation of RNA and chromatin accessibility within a single cell, presenting a comprehensive view of cellular function.
- Visium Platform: The Visium platform represents a revolutionary step in tissue analysis, providing researchers with the ability to understand the spatial positioning of biological analytes within tissues at high resolutions. This is crucial for comprehending the complex interplay between cellular components in various biological and pathological states.
- Xenium Platform: Geared towards in situ analysis, the Xenium platform offers an innovative method for analyzing molecular and cellular biology directly within tissue samples. This approach is pivotal for advancing our understanding of complex biological systems and diseases.
